Skip to main content

Oncology Central is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • News
  • Events coverage
  • Features
    • Opinion
    • Journal articles
    • Events calendar
    • Spotlights
    • In Focus

    Follow us on social media

  • Our Journals
  • Topic
    • Prevention, detection and screening
      • Biomarkers
      • Diagnostics
      • Epidemiology
      • Genetics & genomics
      • Prevention & screening
    • Bench to bedside
      • Cancer biology
      • Clinical trials
      • Drug approvals
      • Drug development
      • Emerging technologies
      • Industry & business
      • Preclinical research
    • Treatments
      • Chemotherapy
      • Immuno-oncology
      • Personalized & precision medicine
      • Radiology
      • Surgery
      • Targeted therapies
    • Supportive oncology
      • Palliative care
      • Patient perspectives
      • Quality of life
      • Survivorship
      • Virtual healthcare

    Follow us on social media

  • Disease specialty
    • Breast
    • Colorectal
    • Endocrine
    • Gastrointestinal
    • Genitourinary
    • Gynecologic
    • Head & neck
    • Hematologic
    • Hepatic
    • Lung
    • Neurologic
    • Pancreatic
    • Prostate
    • Rare tumors
    • Renal
    • Skin

    Follow us on social media

  • Multimedia
    • Videos
    • Podcasts
    • Infographics
    • Webinars
    • Downloadable eBooks

    Follow us on social media

  • Register
[COFFEE CHAT] The emotional and psychological impact of hepatocellular carcinoma on patients, families and caregivers WATCH NOW

Virtual healthcare

The COVID-19 pandemic meant that patients were unable to continue in-person care. Due to this, virtual healthcare has evolved over the last few years, forcing the healthcare system, including oncology, to evolve as quickly as possible.

View more
The speed at which our understanding of the role of virtual healthcare in cancer care has grown, means that studies are still needed to help this upcoming field transition from a temporary solution during the pandemic, to a permanent part of the cancer care experience.

A large part of virtual healthcare is telehealth, also known as telemedicine, and is healthcare provided by health care professionals (HCPs) using electronic devices such as symptom monitoring devices, including apps, video calls, phone calls, email messages and text messages. Despite telehealth improving the accessibility of healthcare, many feel that in-person visits are preferable for promoting a connection with patients and HCPs, as well as difficult conversations being better handled in person. Challenges for telehealth include lack of high-speed internet, language barriers and lack of knowledge with technology. This may lead to disparities within telehealth in oncology and exacerbate existing disparities.

As well as telehealth, large parts of clinical trials can now be performed virtually. For example, providing patients with the information that they need to decide whether to take part in a clinical trial can usually be done completely virtually. A large benefit of this could be faster clinical trial recruitment.

Looking towards the future, technologies such as artificial intelligence (AI) and virtual reality could also aid in cementing telehealth into oncology clinical practice. Many experts think that the future will involve a mixture of telehealth and in-person care, to produce the optimal patient care experience. The focus is now on making virtual healthcare as available, accessible and as simple as possible for every patient to use.

  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Expert Panel
  • Journals
  • Permissions and content ownership policy
  • Press release policy
  • Whitelist emails

Contact

Contact Us

Office info

Oncology Central is powered by Taylor & Francis Group

Oncology Central, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Oncology Central